DCBY02 / DynamiCure Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DCBY02 / DynamiCure Biotech
NCT05496595: DCBY02 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Terminated
1
5
US
DCBY02
DynamiCure Biotechnology
Advanced or Metastatic Solid Tumors
02/24
02/24

Download Options